MyFinsight
Home
Blog
About
ENvue Medical, Inc. (FEED)
ENvue Medical, Inc. (FEED)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$2,718K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the issuance of co...
Stock-based compensation
Prepaid expenses and other accou...
Others
Negative Cash Flow Breakdown
Net loss
Repurchase of series x preferred...
Change in fair value of warrant ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
Effects of currency translation on cash and cash equivalents
0
-
-
Cash acquired in envue merger
0
-
148
Purchase of property and equipment
27
17
60
Net cash (used in) provided by investing activities
-27
-17
88
Proceeds from issuance of notes payable to related party
-
-
1,300
Proceeds from issuance of convertible note payable from related party
0
-
-
Payments of note payable to related party
0
-
1,300
Payments of short-term loans to related party
0
-
1,777
Proceeds from issuance of short-term loan payable
0
-
360
Proceeds from exercise of options and warrants
0
-
102
Proceeds from the issuance of common stock, preferred stock and warrants, net
3,074
3,900
19,089
Other
-
-
12
Repurchase of series x preferred stock
1,480
1,560
5,000
Impairment of goodwill and long-lived assets
-
-
11,154
Net cash provided by financing activities
1,594
2,340
12,786
Issuance cost allocated to warrant liability
0
-
1,420
Depreciation and amortization
219
217
897
Stock-based compensation
2,048
-
-
Non-cash interest expense
0
30
239
Other
-
-
19
Changes in deferred income taxes, net
-
-
-373
Change in fair value of warrant liability
693
-17
6,204
Trade receivable
-126
43
179
Prepaid expenses and other accounts receivable
-443
943
96
Inventory
315
-71
-249
Trade payables
133
-13
552
Other accounts payable and accrued expenses
240
357
1,025
Deferred revenue
0
-175
160
Operating right-of-use asset
-57
-11
-71
Operating lease liabilities
-52
-19
-85
Accrued severance pay, net
2
-
-36
Net loss
-4,899
-3,822
-18,185
Net cash used in operating activities
-2,691
-4,312
-9,372
Net increase (decrease) in cash, cash equivalents and restricted cash
-1,124
-1,989
3,502
Cash, cash equivalents and restricted cash at beginning of period
2,265
4,254
752
Cash, cash equivalents and restricted cash at end of period
1,141
2,265
4,254
Cash and cash equivalents
1,084
-
-
Restricted cash at end of period
57
-
-
Total cash, cash equivalents and restricted cash
1,141
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
issuance of common stock,...
$3,074K
Net cash provided by
financing activities
$1,594K
Canceled cashflow
$1,480K
Net increase
(decrease) in cash, cash...
-$1,124K
Canceled cashflow
$1,594K
Stock-based compensation
$2,048K
Prepaid expenses and
other accounts...
-$443K
Other accounts
payable and accrued...
$240K
Depreciation and
amortization
$219K
Trade payables
$133K
Trade receivable
-$126K
Operating right-of-use
asset
-$57K
Accrued severance pay,
net
$2K
Repurchase of series x
preferred stock
$1,480K
Net cash used in
operating activities
-$2,691K
Canceled cashflow
$3,268K
Net cash (used in)
provided by investing...
-$27K
Net loss
-$4,899K
Change in fair value of
warrant liability
$693K
Inventory
$315K
Operating lease
liabilities
-$52K
Purchase of property and
equipment
$27K
Buy us a coffee